Lupin LimitedNSE: LUPIN

Press Release Aug 29 2022

· Issued by Lupin Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-29-2022-5

Lupin Limited has informed the Exchange about press release dated 29-Aug-2022 titled Lupin Receives Tentative Approval from U.S. FDA for Dasatinib Tablets.

View Attachment

6ix hasn’t read this filing yet.

Lupin Limited on 6ix

Earlier from Lupin

Later from Lupin

All Lupin news releases